Article 74V35 RFK Jr. rewrites CDC panel's charter, opening door to anti-vaccine quacks

RFK Jr. rewrites CDC panel's charter, opening door to anti-vaccine quacks

by
Beth Mole
from Ars Technica - All content on (#74V35)

As expected, anti-vaccine Health Secretary Robert F. Kennedy Jr. has significantly rewritten the charter for a federal vaccine advisory panel. The edits give him more power to appoint his like-minded allies as federal advisors, shift the panel's focus to alleged vaccine injuries and risks, and welcome fringe groups and anti-vaccine organizations to the Centers for Disease Control and Prevention.

On Monday, a notice in the Federal Register indicated Kennedy renewed the charter for the CDC's Advisory Committee on Immunization Practices (ACIP), which is done every two years, with the last term having ended April 1. But instead of the usual humdrum renewal process, the notice on Monday indicated big changes were coming to the defining document of the panel, which heavily influences federal vaccine policy that, in turn, influences state requirements and insurance coverage.

The new charter, published Thursday, reveals new responsibilities that redirect advisors toward topics and terms dear to anti-vaccine activists. For instance, ACIP members will now be responsible for "considering analysis of cumulative effects of vaccines and their constituent components." This wording echoes explicit goals of Kennedy's anti-vaccine allies, who aim to pin complex conditions-such as allergies, autism, and neurodevelopmental conditions-on combinations of vaccinations or common ingredients in those shots, such as aluminum adjuvants. This is a pivot from anti-vaccine activists' earlier attacks that focused on individual vaccines, such as the false, fraudulent claim that the measles vaccine is linked to autism-a claim that has been roundly debunked by dozens of high-quality studies.

Read full article

Comments

External Content
Source RSS or Atom Feed
Feed Location http://feeds.arstechnica.com/arstechnica/index
Feed Title Ars Technica - All content
Feed Link https://arstechnica.com/
Reply 0 comments